EHA 2026 – Latest Advances in Hematology

From June 10 to 14, 2026, Magna Pharmacia attended the EHA Congress (European Hematology Association Congress) in Stockholm, Sweden, one of the most significant international events in the field of hematology.

The congress provided insight into the latest advances in the diagnostics and treatment of hematological malignancies, as well as coagulation disorders. Of particular importance were lectures dedicated to multiple myeloma and chronic lymphocytic leukemia — conditions that represent a significant segment of secondary immunodeficiencies — as well as dedicated sessions on the use of intravenous immunoglobulins.

Special attention was drawn to lectures on new technologies that already have a substantial clinical impact on the diagnostics, monitoring, and treatment of hematological patients, opening new possibilities for improving treatment outcomes. Participation in EHA 2026 represented a valuable opportunity to acquire new knowledge, exchange experiences with leading experts in the field of hematology, and follow innovations that contribute to the advancement of modern clinical practice and the quality of healthcare.